Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Rituximab × Clear all

Sponsor

Conditions

Lymphoma 150 Leukemia, Lymphocytic, Chronic, B-Cell 138 Lymphoma, Non-Hodgkin 135 Lymphoma, Follicular 117 Lymphoma, Large B-Cell, Diffuse 114 Lymphoma, Mantle-Cell 81 Leukemia 63 Lymphoma, B-Cell, Marginal Zone 59 Waldenstrom Macroglobulinemia 44 Burkitt Lymphoma 37 Lymphoma, B-Cell 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Hodgkin Disease 32 Recurrence 22 Lymphoma, Large-Cell, Immunoblastic 22 Neoplasms 15 Myelodysplastic Syndromes 15 Lymphoma, Large-Cell, Anaplastic 13 Multiple Myeloma 12 Leukemia, Myeloid, Acute 12 Hematologic Neoplasms 9 Lymphoma, T-Cell, Cutaneous 7 Lymphoma, Extranodal NK-T-Cell 7 Leukemia, Prolymphocytic 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Hairy Cell 7 Intraocular Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡